Invesaro

Stocks Comparison

Hims & Hers Health vs Teladoc Health: revenue, profit, margins and growth compared

Hims & Hers Health brought in $2.3B of revenue in fiscal 2025, Teladoc Health $2.5B in fiscal 2025. Revenue changed by +59.0% at Hims & Hers Health and -1.5% at Teladoc Health on the year before, so Hims & Hers Health grew faster. Hims & Hers Health kept 5.5% of its revenue as net profit, Teladoc Health -7.9%. Free cash flow was $57.4M at Hims & Hers Health and $285.5M at Teladoc Health.

Side by side, latest fiscal year

HIMSTDOC
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$2.3B$2.5B
Revenue growth+59.0%-1.5%
Net income$128.4M-$200.3M
Net margin5.5%-7.9%
Free cash flow$57.4M$285.5M
Free cash flow margin2.4%11.3%
Earnings per share (diluted)$0.51-$1.14
Cash$228.6M$781.1M
Debtn/an/a
Price to earnings57.7n/a
Market value$6.9B$1.1B
Dividend yieldn/an/a
Rank by revenue in sector#99 of 523 · Health care#96 of 523 · Health care

Over the years

Revenue
HIMS FY2019: $82.6MHIMS FY2020: $148.8MHIMS FY2021: $271.9MHIMS FY2022: $526.9MHIMS FY2023: $872MHIMS FY2024: $1.5BHIMS FY2025: $2.3BTDOC FY2018: $417.9MTDOC FY2019: $553.3MTDOC FY2020: $1.1BTDOC FY2021: $2BTDOC FY2022: $2.4BTDOC FY2023: $2.6BTDOC FY2024: $2.6BTDOC FY2025: $2.5BFY18FY19FY20FY21FY22FY23FY24FY25
HIMS $2.3BTDOC $2.5B
Net income
HIMS FY2019: -$72.1MHIMS FY2020: -$18.1MHIMS FY2021: -$107.7MHIMS FY2022: -$65.7MHIMS FY2023: -$23.5MHIMS FY2024: $126MHIMS FY2025: $128.4MTDOC FY2018: -$97.1MTDOC FY2019: -$98.9MTDOC FY2020: -$485.1MTDOC FY2021: -$428.8MTDOC FY2022: -$13.7BTDOC FY2023: -$220.4MTDOC FY2024: -$1BTDOC FY2025: -$200.3MFY18FY19FY20FY21FY22FY23FY24FY25
HIMS $128.4MTDOC -$200.3M
Net margin
HIMS FY2019: -87.3%HIMS FY2020: -12.2%HIMS FY2021: -39.6%HIMS FY2022: -12.5%HIMS FY2023: -2.7%HIMS FY2024: 8.5%HIMS FY2025: 5.5%TDOC FY2018: -23.2%TDOC FY2019: -17.9%TDOC FY2020: -44.3%TDOC FY2021: -21.1%TDOC FY2022: -567.5%TDOC FY2023: -8.5%TDOC FY2024: -39.0%TDOC FY2025: -7.9%FY18FY19FY20FY21FY22FY23FY24FY25
HIMS 5.5%TDOC -7.9%
Revenue growth
HIMS FY2020: +80.2%HIMS FY2021: +82.8%HIMS FY2022: +93.8%HIMS FY2023: +65.5%HIMS FY2024: +69.3%HIMS FY2025: +59.0%TDOC FY2019: +32.4%TDOC FY2020: +97.7%TDOC FY2021: +85.8%TDOC FY2022: +18.4%TDOC FY2023: +8.1%TDOC FY2024: -1.3%TDOC FY2025: -1.5%FY19FY20FY21FY22FY23FY24FY25
HIMS +59.0%TDOC -1.5%
Free cash flow
HIMS FY2022: -$33.7MHIMS FY2023: $47MHIMS FY2024: $198.3MHIMS FY2025: $57.4MTDOC FY2018: -$8.9MTDOC FY2019: $26.4MTDOC FY2020: -$57.5MTDOC FY2021: $185.5MTDOC FY2022: $172.8MTDOC FY2023: $338.6MTDOC FY2024: $282.9MTDOC FY2025: $285.5MFY18FY19FY20FY21FY22FY23FY24FY25
HIMS $57.4MTDOC $285.5M

Fiscal years as each company reports them; the two may end in different months.

Questions about Hims & Hers Health and Teladoc Health

Which is bigger by revenue, Hims & Hers Health or Teladoc Health?

Teladoc Health is bigger by revenue: $2.5B in fiscal 2025, against $2.3B for Hims & Hers Health in fiscal 2025.

Which keeps more of its revenue as profit, Hims & Hers Health or Teladoc Health?

Hims & Hers Health had a net margin of 5.5% in fiscal 2025; Teladoc Health had -7.9% in fiscal 2025.

Which grew revenue faster, Hims & Hers Health or Teladoc Health?

In their latest fiscal years revenue changed by +59.0% at Hims & Hers Health and -1.5% at Teladoc Health.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies